Revolutionizing Data Independent Acquisition on q-OT-IT Tribrid Mass Spectrometers

Significance of the topic

Data independent acquisition (DIA) offers comprehensive and reproducible proteome profiling by fragmenting all ions in defined m/z windows. Its application to whole cell lysates demands high sensitivity and throughput to resolve complex samples and quantify low-abundance proteins. q-OT-IT Tribrid mass spectrometers, notably the Orbitrap Fusion Lumos, combine speed, resolution, and sensitivity to advance DIA workflows.

Objectives and Overview of the Study

This study aims to demonstrate a DIA strategy on a q-OT-IT Tribrid MS system for complete quantification of whole cell lysates. A spectral library was generated from two non-small cell lung cancer (NSCLC) lines—one Erlotinib-sensitive, one resistant—followed by DIA-based quantification and comparative analysis.

Methodology and Used Instrumentation

• Sample preparation: HeLa digest standard QC and NSCLC cell lysates reduced, alkylated, digested, spiked with Biognosys HRM peptides.
• Chromatography: Easy nLC 1000 nano-HPLC, reversed-phase C18 column, 120 min gradient (5–25% B, then 25–40% B).
• Library building: Orbitrap Fusion Lumos DDA MS, MS1 120 000 resolution, HCD MS/MS 30 000 resolution, 3 s cycle.
• DIA acquisition: 400–1000 m/z range, 40 windows of 15 Da, MS2 30 000 resolution, MS1 120 000 resolution, max inject 60 ms.
• Data analysis: SEQUEST HT in Proteome Discoverer 1.4 (1% FDR) to build library; Spectronaut 7 for DIA quantification, using dynamic iRT, interference correction, cross-run normalization, statistical filtering (q<0.01, CV<20%).

Main Results and Discussion

Over 5200 proteins and 44000 peptides were quantified per run with CV <20%. The combined library comprised ~6700 proteins and ~60000 peptides. Orbitrap Fusion Lumos yielded ~25% more quantifiable proteins and peptides at low sample loads than the previous generation. DIA reproducibility showed median CV ~9.2%. Statistical comparison between Erlotinib-resistant and sensitive lines identified ~1200 proteins with >2-fold change (q<0.01). Pathway analysis revealed downregulation of MAPK components and upregulation of mTOR pathway effectors. Results correlated closely with orthogonal TMT and SILAC measurements.

Benefits and Practical Applications of the Method

• Deep proteome coverage with high reproducibility and throughput.
• Sensitivity to detect low-abundance proteins in whole cell lysates.
• Robust comparative analysis for drug response and biomarker discovery.
• Applicability in QA/QC and clinical proteomics workflows.

Future Trends and Potential Applications

Advancements may include refined isolation window schemes, higher scan speeds, library-free DIA, integration with machine learning for data interpretation, and adaptation to single-cell proteomics and clinical diagnostics.

Conclusion

DIA on the q-OT-IT Tribrid Orbitrap Fusion Lumos system enables comprehensive, reproducible quantification of complex proteomes with superior sensitivity and throughput compared to previous generations, facilitating advanced biological and translational studies.

References

• Bomgarden R, et al. Cancer Research 74(6), 1608–1617 (2014).
• Senko MW, et al. Analytical Chemistry 85(23), 11710–11714 (2013).
• Bruderer R, et al. Molecular & Cellular Proteomics 14(3), Epub ahead of print (2015).